The company utilizes its proprietary Versamune platform technology to activate and direct the human immune system to target and attack cancer cells. PDS Biotech develops products to treat various types of cancers, including head and neck, prostate, breast, cervical, anal, and other cancers. They also offer immunotherapy products for non-viral cancers and a pandemic influenza vaccine. Founded in 2005 and headquartered in New Jersey, PDS Biotech is committed to developing novel therapies based on the Versamune platform to save and improve the lives of cancer patients worldwide.